To Evaluate the Efficacy and Safety of 'NDTx-01' in Patients With ASD or SCD

Clinical trial NCT06446193 · COMPLETED

Trial details

NCT number: NCT06446193
Sponsor: Neudive Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Autism Spectrum Disorder Social Communication Disorder

Start date: 2024-08-14
Primary completion: 2025-02-06
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.